Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
The Korean Journal of Parasitology ; : 153-157, 2021.
Article in English | WPRIM | ID: wpr-896153

ABSTRACT

This study reports the first two clinical cases of spirometrosis caused by Spirometra sp. in cats in Korea. In these two cases, the cats vomited, and long proglottids of tapeworm were recovered. The sick cats presented with anorexia and lethargy. However, they unexpectedly showed no diarrhea, which is the main symptom of spirometrosis. Based on a fecal floatation test as well as morphological and molecular analyses, the parasite was diagnosed as Spirometra sp. The 2 cases were treated with praziquantel. This study suggests regular monitoring of health and deworming in companion animals, even when animals are well cared for, with regular preventive medication. Additionally, spirometrosis should be considered in the differential diagnosis in cases of gastrointestinal symptoms in Spirometra endemic areas.

2.
Psychiatry Investigation ; : 1131-1136, 2021.
Article in English | WPRIM | ID: wpr-918727

ABSTRACT

Objective@#Relationship between hair cortisol concentration (HCC) and stress-related psychological measures are inconclusive, possibly due to overlooked heterogeneity regarding childhood trauma and a lack of comprehensive research on stress-related psychological factors. This study aims to compare young adults without history of childhood trauma to young adults who experienced childhood trauma using HCC and various stress-related psychological factors, as well as investigate the impacts of childhood trauma on the association between HCC and stress-related psychological measures. @*Methods@#A total of 206 young, healthy adults were recruited. We divided participants into two groups depending on whether or not they had suffered moderate-to-severe childhood trauma (CT+ and CT-) and compared HCC and various stress-related psychological measures between groups. Using multiple linear regression analyses, we assessed the associations between HCC and stress-related psychological measures for each group. @*Results@#We found no difference between the groups in HCC or the reported number of stressful life events in the past year; however, CT+ individuals reported higher stress perception, more depressive and anxiety-related symptoms, and more difficulties in emotion regulation than CT- individuals. HCC was associated with emotion dysregulation among the CT- individuals, but not among the CT+ individuals. @*Conclusion@#These findings suggest that history of childhood trauma should be considered in studies using HCC as a biomarker for stress in young adults. Furthermore, HCC might be a useful biomarker of stress and stress-related emotion dysregulation in individuals without moderate-to-severe childhood trauma.

3.
The Korean Journal of Parasitology ; : 153-157, 2021.
Article in English | WPRIM | ID: wpr-903857

ABSTRACT

This study reports the first two clinical cases of spirometrosis caused by Spirometra sp. in cats in Korea. In these two cases, the cats vomited, and long proglottids of tapeworm were recovered. The sick cats presented with anorexia and lethargy. However, they unexpectedly showed no diarrhea, which is the main symptom of spirometrosis. Based on a fecal floatation test as well as morphological and molecular analyses, the parasite was diagnosed as Spirometra sp. The 2 cases were treated with praziquantel. This study suggests regular monitoring of health and deworming in companion animals, even when animals are well cared for, with regular preventive medication. Additionally, spirometrosis should be considered in the differential diagnosis in cases of gastrointestinal symptoms in Spirometra endemic areas.

4.
Korean Journal of Veterinary Research ; : 93-96, 2020.
Article | WPRIM | ID: wpr-836791

ABSTRACT

An 11-year-old female mixed-breed dog admitted due to anorexia and vomiting. Radiography showed 7.6-mm uroliths in the right proximal ureter and an enlarged kidney. Type 1 emphysematous pyelonephritis (EPN) was diagnosed using computed tomography (CT) in the awake dog. Right ureteronephrectomy was performed, and Escherichia coli was isolated. The stone was consisted of 80% calcium oxalate. At the 6-month follow-up, no complications were observed. This is the first report of EPN caused by calcium oxalate in a dog. In addition, we suggest performing CT in weak animals to diagnose EPN without anesthesia.

5.
Journal of Veterinary Science ; : e5-2019.
Article in English | WPRIM | ID: wpr-758902

ABSTRACT

Long-term maintenance of transplanted organs is one of the major factors that increases survival time of recipients. Although obtaining a major histocompatibility complex (MHC)-matched donor with the recipient is essential for successful organ transplantation, there have been limited reports on MHC matching between dogs. In this study, we analyzed the canine MHC matching rates using Maltese, one of the most popular purebred dogs, and mongrel dogs in Korea. Genomic DNA was extracted from blood leukocytes and DNA was amplified by polymerase chain reaction with primers specific to MHC microsatellite markers. The MHC matching degree was confirmed by the microsatellite markers using polyacrylamide gel electrophoresis. The MHC matching rates of each donor-recipient groups including Maltese-Maltese, mongrel-mongrel and Maltese-mongrel were 4.76%, 5.13% and 6.67%, respectively. There were no significant differences in the MHC matching degree between each group. These results demonstrate that MHC-matched donors could be selected from other breeds as much as from the same breed for transplantation. Knowledge of the MHC matching degree of purebred and mongrel dogs would offer valuable information not only for improving the success rate of organ transplantation surgery in canine patients but also for transplantation research using experimental canine models.


Subject(s)
Animals , Dogs , Humans , DNA , Electrophoresis, Polyacrylamide Gel , Korea , Leukocytes , Major Histocompatibility Complex , Microsatellite Repeats , Organ Transplantation , Polymerase Chain Reaction , Tissue Donors , Transplants
6.
Psychiatry Investigation ; : 499-504, 2018.
Article in English | WPRIM | ID: wpr-714473

ABSTRACT

OBJECTIVE: This study determined whether cognitive behavioral therapy for insomnia (CBT-i) decreased the need for sleep medications and produced better treatment outcomes than pharmacotherapy alone. METHODS: We reviewed data from patients with insomnia in the outpatient clinic of a general hospital between 2009 and 2015. We compared 41 patients who received five sessions of CBT-i with 100 age- and sex-matched patients who received pharmacotherapy only. We evaluated the change in prescription for sleep (i.e., antidepressants, hypnotics, and others) between the first and last visits using repeated measures analysis of variance (ANOVA). Clinical global impressions and completion status at the last visit were assessed using the chisquare test. RESULTS: We found a significant decrease in the prescription rate and the dosage of hypnotics among patients who received CBT-i when compared with control patients. There was no significant change in the dosage of antidepressants between the two groups. Achievement of case closure was better in the CBT-i group at the trend level. Clinical global impression at the last visit was not significantly different. CONCLUSION: These results show that CBT-i reduces the need for hypnotics among insomnia patients. Our results indicate that CBT-i offers additional benefits beyond improving sleep characteristics and thus provides another reason for recommending CBT-i as a first-line treatment for insomnia.


Subject(s)
Humans , Ambulatory Care Facilities , Antidepressive Agents , Cognitive Behavioral Therapy , Drug Therapy , Hospitals, General , Hypnotics and Sedatives , Prescriptions , Sleep Initiation and Maintenance Disorders
7.
Sleep Medicine and Psychophysiology ; : 74-81, 2018.
Article in Korean | WPRIM | ID: wpr-738921

ABSTRACT

OBJECTIVES: Insomnia is one of the major concerns in the elderly population. Cognitive behavioral treatment for insomnia is the first line treatment option, but there are some limitations including time and cost burdens and the requirement for sufficient cognitive resources to obtain a proper treatment effect. The Brief intervention for insomnia (BII) is a treatment that focuses on behavioral aspects of insomnia in primary care practices. The purpose of this study was to evaluate the effects of BII in community-dwelling older adults. METHODS: A total of 47 older adults with insomnia were enrolled from community centers between May 2016 and January 2018. They participated in the BII program for three weeks. We gathered sleep-related participant information with using the Pittsburgh sleep quality index (PSQI), the Sleep hygiene index, and a sleep diary. Clinical efficacy was evaluated by comparing total sleep time (TST), sleep latency (SL), waking after sleep onset (WASO), and sleep efficiency (SE) before and after the treatment. RESULTS: There was significant improvement in sleep-related features after BII. Global score and sleep quality from the PSQI, freshness, and WASO from the sleep diary showed statistically significant improvement. CONCLUSION: We found BII showed positive clinical efficacy in community dwelling older adults, especially from the perspective of subjective sleep quality and WASO. This finding implies that BII can be effectively applied for the managment of elderly insomnia patients in a community setting.


Subject(s)
Adult , Aged , Humans , Hygiene , Independent Living , Primary Health Care , Sleep Initiation and Maintenance Disorders , Treatment Outcome
8.
Sleep Medicine and Psychophysiology ; : 38-45, 2017.
Article in Korean | WPRIM | ID: wpr-45282

ABSTRACT

OBJECTIVES: Sleep disturbance is a very rapidly growing disease with aging. The purpose of this study was to investigate the prevalence of sleep disturbances and its predictive factors in a three-year cohort study of people aged 60 years and over in Korea. METHODS: In 2012 and 2014, we obtained data from a survey of the Korean Social Life, Health, and Aging Project. We asked participants if they had been diagnosed with stroke, myocardial infarction, angina pectoris, arthritis, pulmonary tuberculosis, asthma, cataract, glaucoma, hepatitis B, urinary incontinence, prostate hypertrophy, cancer, osteoporosis, hypertension, diabetes, hyperlipidemia, or metabolic syndrome. Cognitive function was assessed using the Mini-Mental State Examination for dementia screening in 2012, and depression was assessed using the Center for Epidemiologic Studies Depression Scale in 2012 and 2014. In 2015, a structured clinical interview for Axis I psychiatric disorders was administered to 235 people, and sleep disturbance was assessed using the Pittsburgh Sleep Quality Index. The perceived stress scale and the State-trait Anger Expression Inventory were also administered. Logistic regression analysis was used to predict sleep disturbance by gender, age, education, depression score, number of coexisting diseases in 2012 and 2014, current anger score, and perceived stress score. RESULTS: Twenty-seven percent of the participants had sleep disturbances. Logistic regression analysis showed that the number of medical diseases three years ago, the depression score one year ago, and the current perceived stress significantly predicted sleep disturbances. CONCLUSION: Comorbid medical disease three years previous and depressive symptoms evaluated one year previous were predictive of current sleep disturbances. Further studies are needed to determine whether treatment of medical disease and depressive symptoms can improve sleep disturbances.


Subject(s)
Aged , Humans , Aging , Anger , Angina Pectoris , Arthritis , Asthma , Cataract , Cognition , Cohort Studies , Comorbidity , Dementia , Depression , Education , Epidemiologic Studies , Follow-Up Studies , Glaucoma , Hepatitis B , Hyperlipidemias , Hypertension , Hypertrophy , Korea , Logistic Models , Mass Screening , Myocardial Infarction , Osteoporosis , Prevalence , Prostate , Sleep Initiation and Maintenance Disorders , Stroke , Tuberculosis, Pulmonary , Urinary Incontinence
9.
Korean Journal of Psychosomatic Medicine ; : 136-144, 2017.
Article in Korean | WPRIM | ID: wpr-738881

ABSTRACT

OBJECTIVES: Cognitive complaints are reported frequently after breast cancer treatments. The causes of cognitive decline are multifactorial, a result of the effect of cancer itself, chemotherapy, and psychological factors such as depression and anxiety. However, cognitive decline does not always correlate with neuropsychological test performance. The purpose of this study was to examine the relationship of subjective cognitive decline with objective measurement and to explore associated factors of cognitive function in breast cancer survivors. METHODS: We included 29 breast cancer survivors who complain cognitive decline at least 6 months after treatment and 20 age-matched healthy controls. Neuropsychological tests were performed in all participants. Multivariable regression analysis evaluated associations between neuropsychological test scores and psychological distress including depression and anxiety, also considering age, education, and comorbidity. RESULTS: There were no statistically significant differences in neuropsychological test performances. However, the breast cancer survivors showed a significantly higher depression(p=0.002) and anxiety(p < 0.001) than the healthy controls did. Among the cancer survivors, poorer executive function was strongly associated with higher depression(β=−0.336, p=0.001) and anxiety(β=−0.273, p=0.009), after controlling for age, education, and comorbidity. In addition, poorer attention was also significantly related with depression(β=−0.375, p=0.023) and anxiety (β=−0.404, p=0.013). CONCLUSIONS: The results of this study showed the discrepancies between subjective complaints and objective measures of cognitive function in breast cancer survivors. It suggests that subjective cognitive decline could be indicators of psychological distress such as depression and anxiety.


Subject(s)
Humans , Anxiety , Breast Neoplasms , Breast , Cognition , Comorbidity , Depression , Drug Therapy , Education , Executive Function , Neuropsychological Tests , Psychology , Survivors
10.
Korean Journal of Nephrology ; : 99-105, 2001.
Article in Korean | WPRIM | ID: wpr-118016

ABSTRACT

Hyperhomocysteinemia is an independent risk factor for atherosclerotic complications in adult patients with chronic renal failure. Data on hyperhomocysteinemia in children with chronic renal failure are not sufficient. In the present study we investigated plasma homocysteine concentration status in children with chronic renal failure, factors correlating plasma homocysteine concentration, and the effect of folate dose increase. We measured fasting plasma homocysteine, folate, vitamin B12, creatinine concentration in 32 children on dialysis and 21 non-renal patients as controls. Then, 21 children of 32 on dialysis were prescribed 2.5mg folic acid daily, instead of 0.8mg daily. Mean fasting plasma homocysteine concentration was 13.8 micromol/L in end-stage renal disease patients and 7.5micromol/L in controls. Serum folate and vitamin B12 concentrations are higher in ESRD patients. Patients on peritoneal dialysis showed higher serum folate concentrations than patients on hemodialysis. Homocysteine levels were significantly correlated with age and creatinine, and negatively correlated with folate and vitamin B12 levels in patients. After 4 weeks of folic acid dose increase, homocysteine levels of patients on hemodialysis were decreased, which contrast with patients on peritoneal dialysis. Children with end-stage renal disease have elevated plasma homocysteine concentrations with 0.8mg folic acid daily, and folic acid dose increase to 2.5mg daily lowers homocysteine level in patients on hemodialysis. It is suggested that folic acid dose be increased for children on hemodialysis to decrease homocysteine level, although a beneficial effect has to be proven.


Subject(s)
Adult , Child , Humans , Creatinine , Dialysis , Fasting , Folic Acid , Homocysteine , Hyperhomocysteinemia , Kidney Failure, Chronic , Methylenetetrahydrofolate Reductase (NADPH2) , Peritoneal Dialysis , Plasma , Renal Dialysis , Risk Factors , Vitamin B 12
SELECTION OF CITATIONS
SEARCH DETAIL